Medoc expands its Services to serve CROs – Improving Success Rates of Clinical Trials

20 September 2016
617 Views

With a proven track-record offering advanced neuro-diagnostic medical systems to leading research institutions around the world, Medoc now expands its reach to serve the CRO and pharmaceutical markets.

Mr. Amir Haiman, General Manager QST Division & CTO, commented on Medoc’s recent expansion to serve the pharmaceutical industry: “With vast experience in medical research, advanced technologies and creative solutions to complex trial challenges, Medoc is the perfect partner for CROs looking to optimize their pain-related clinical trials anywhere in the world.”

Want to know more about it? Click here for further information.